Occuity, doubles team with the appointment of new staff in key positions including, programme management, engineering, marketing and finance

Following on from Occuity's successful investment round, our teams have been hard at work accelerating the development of our first...

Following on from Occuity's successful investment round, our founder and CEO Dr. Dan Daly, spoke to the Angel Investment Network about...

Occuity are delighted to announce the successful raise of more than £1m. The raise will enable us to continue the development of novel...

Occuity unveil the latest designs for the desktop charging cradle and calibration artefact for the new Optical Non-Contacting Pachymeter...

Occuity have released a video showing the fully handheld optical pachymeter prototype taking the corneal measurement from a model eye. ...

Despite the COVID-19 lockdown, Occuity remain on track to bring the world's first optical handheld pachymeter to market next year. With...

On the 9th April 2020 Occuity received confirmation that the initial rounds of investment in Occuity were approved by HMRC under the...

Occuity have secured grant funding from Innovate UK to further enhance and test their novel technology for monitoring glucose levels...

At a busy investor day held at Occuity's offices in Reading, Occuity were able to demonstrate the rapid progress towards the new handheld...

Occuity will be unveiling the world's first non-contacting optical handheld Pachymeter at Optrafair 20/20 at the NEC, Birmingham, UK...